Red blood cell count (RBC): what it measures, normal levels for men and women, and what high or low red cells mean

The red blood cell count is a count: the number of erythrocytes in a given volume of blood, reported in millions per microliter (or trillions per liter, the same number). Red cells are made in the bone marrow under the control of erythropoietin from the kidney, live about 120 days, and are removed by the spleen; the count reflects the balance between production, lifespan and loss, and is diluted or concentrated by the amount of plasma they float in.

Modern analyzers count the cells individually as they pass a detector, so the RBC is a direct measurement, and the analyzer derives the indices from it: MCV (average cell volume) is hematocrit divided by RBC, MCH (hemoglobin per cell) is hemoglobin divided by RBC, and MCHC is hemoglobin divided by hematocrit. That arithmetic is why the count is most informative alongside the others.

The count can disagree with hemoglobin in instructive ways. In thalassemia trait the RBC is normal or high while hemoglobin is low, because the marrow makes many small, pale cells; in iron deficiency both fall together; in B12 or folate deficiency the RBC falls more than hemoglobin because each remaining cell is large and full. The Mentzer index (MCV divided by RBC) uses exactly this to separate iron deficiency from thalassemia trait before iron studies return.

The RBC is part of every complete blood count, so it is checked at most annual physicals, before surgery and whenever anemia or a blood disorder is suspected: fatigue, breathlessness, palpitations, dizziness, pallor, heavy periods, gastrointestinal bleeding, or a family history of thalassemia or sickle cell disease. It is monitored in chronic kidney disease, cancer treatment, inflammatory disease and any condition that affects the marrow.

A high count is looked for in smokers, people living at altitude, those with chronic lung disease or sleep apnea, and men on testosterone therapy, because a high red cell mass thickens the blood. In Mediterranean, Middle Eastern, South and Southeast Asian and African populations an RBC that is high while hemoglobin is low or borderline is the classic clue to thalassemia trait, which is important to recognize before pregnancy and before iron is prescribed for an "anemia" that is not iron deficiency.

The red blood cell count comes on every complete blood count, with or without a differential, which a doctor can order or you can order online through TestWell for a draw at a Quest or Labcorp patient service center; a licensed physician reviews the order and results post to your portal within one to three business days against sex-specific ranges. Adding ferritin, iron and TIBC or B12 and folate to the same draw answers the usual follow-up questions without a second visit.

No fasting is needed. Drink normally: dehydration concentrates the blood and raises the RBC, hematocrit and hemoglobin together, and a large fluid intake just before the draw dilutes them slightly. Avoid strenuous exercise in the hours before (it concentrates the blood transiently), and note any blood donation in the previous two months, recent high-altitude travel, smoking, pregnancy and iron or B12 supplements for the ordering physician.

Red cells live four months, so a count that has fallen reflects weeks to months of events, and a repeat after treatment of iron or B12 deficiency is read at six to eight weeks rather than days — though the reticulocyte count, which measures new cells, rises within a week when treatment is working.

Most laboratories report about 4.7 to 6.1 million cells per microliter for adult men and 4.2 to 5.4 million for adult women; some use 4.35 to 5.65 and 3.92 to 5.13. Men run higher because testosterone stimulates red cell production and because women lose iron with menstruation. Newborns are high (4.8 to 7.1 million) and the count falls through infancy, with children typically 4.0 to 5.5 million. Pregnancy lowers the count by dilution from the second trimester.

The count drifts down slightly with age, and a value at the lower edge of the range in an older adult is common. Rather than the count alone, clinicians look at the hemoglobin for whether anemia is present and at the MCV for what kind: a low RBC with a low MCV suggests iron deficiency, a low RBC with a high MCV B12 or folate deficiency, alcohol or liver disease, and a low RBC with a normal MCV blood loss, chronic disease, kidney disease or a marrow problem. A normal or high RBC with a low MCV and low or borderline hemoglobin suggests thalassemia trait.

Units can confuse: 4.5 million per microliter is the same as 4.5 × 10^12 per liter and as 4.5 × 10^6 per microliter, all common ways of printing the same count.

A low RBC is anemia and has the same three mechanisms: too few cells made (iron, B12 or folate deficiency, chronic kidney disease, the anemia of chronic inflammation or disease, an underactive thyroid, marrow disorders, chemotherapy), cells lost (acute or chronic bleeding from the gut, heavy periods, surgery), or cells destroyed early (hemolytic anemias, sickle cell disease, some medications and infections). Pregnancy and overhydration lower the count by dilution without true anemia.

Symptoms are anemia's and depend on how low and how fast the count fell: fatigue, weakness, pale skin, shortness of breath and a racing heart on exertion, headaches, dizziness, cold hands and feet, and trouble concentrating. A mildly low count that developed slowly is often found on a routine CBC in someone who feels well.

The MCV and RDW steer the work-up, and a reticulocyte count tells whether the marrow is responding (high after bleeding or hemolysis, low when production is the problem). Ferritin, iron and TIBC, B12 and folate, kidney function, thyroid and inflammatory markers follow. In an adult man or a post-menopausal woman, iron deficiency is a reason to look for bleeding in the gut rather than simply to replace iron.

The commonest reason for a high RBC is a concentrated sample — dehydration from illness, heat, diuretics or not drinking — which raises RBC, hemoglobin and hematocrit together and settles with fluids. True increases in red cell mass come from the body responding to low oxygen: smoking (carbon monoxide displaces oxygen), living at altitude, chronic lung disease, sleep apnea, heart disease with shunting, obesity hypoventilation; from testosterone, anabolic steroids and erythropoietin; and rarely from kidney or liver tumors that make erythropoietin.

Polycythemia vera is a marrow disorder that overproduces red cells independently of oxygen and is the diagnosis to exclude when the count, hemoglobin and hematocrit are persistently high without a secondary cause; a JAK2 mutation test and an erythropoietin level are the usual next steps. Thalassemia trait raises the count without raising hemoglobin or hematocrit — many small cells — and is not polycythemia.

A genuinely high red cell mass thickens the blood and can cause headaches, dizziness, a flushed face, itching after a warm shower, blurred vision, fatigue and a higher risk of clots; men on testosterone are monitored for it and the dose adjusted if hematocrit climbs above about 54 percent.

The count is one of three measures of red cell mass on the CBC and is interpreted with the other two: hemoglobin defines anemia, hematocrit confirms it, and the RBC with the MCV says what kind of cells are present. RDW adds how varied the cells are in size, rising early in iron and B12 deficiency and in mixed pictures; the reticulocyte count adds whether the marrow is responding; and a blood smear shows cell shape when the indices are unusual.

Ferritin is the most useful single follow-up for a low count with small cells, B12 and folate for large cells, and hemoglobin electrophoresis for a high count with small cells and a family history. Erythropoietin and JAK2 testing follow a persistently high count without a secondary explanation. On TestWell the CBC with differential carries all of the red cell measures together, and the anemia and iron panels add the follow-up tests to the same draw.